Document is current
Any future updates will be listed below
-
Authors
Li, Haisu
Du, Min
Ru, Xue
Liu, Jianxia
Liu, Lan
Zhang, Shaoqing
Xu, Ying
Xie, Zudan
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2100050071 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Comparison of different propofol target-controlled infusion concentrations in children with autism spectrum disorder undergoing magnetic resonance imaging
https://doi.org/10.1038/s41598-025-26741-3
-
Funding
Funding for this research was provided by:
Chongqing municipal medical scientific research project (2023DBXM003)
Chongqing Science and Technology Bureau’s Technical Innovation and Application Development (CSTB2022TIAD-GPX0007)
- License Information
-
More Information
Article History
Received: 15 February 2025
Accepted: 30 October 2025
First Online: 28 November 2025
Declarations
:
: The authors declare no competing interests.
: The study protocol received approval from the Ethics Committee of the Children’s Hospital of Chongqing Medical University (IRB #139/2021, approved on April 27, 2021) and was prospectively registered in the Chinese Clinical Trial Registry (Registration: No. ChiCTR2100050071, registered on August 16, 2021).
: In accordance with the Declaration of Helsinki, written informed consent was obtained from the parents of all participants.
